Lymphoproliferative disease of the orbit

Current Opinion in Ophthalmology

Volumn 18, Issue 5, 2007, Pages 398-401

  Bernardini, Francesco P ^a,b,c   Bazzan, Mario ^c  

^a Ospedale Evangelico Internazionale   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c Casa di Cura Cellini ^*  (Italy)

Author keywords

Lymphoproliferative disease of the orbit; Orbital lymphoma; Staging of orbital lymphoma; Therapy for orbital lymphoma

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; DOXYCYCLINE FOSFATEX; FLUOROURACIL; PREDNISONE; RITUXIMAB; VINCRISTINE;

BRONCHOSPASM; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHLAMYDIASIS; CHLAMYDOPHILA PSITTACI; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVA DISEASE; DISEASE COURSE; DRUG EFFICACY; EYE CANCER; FLOW CYTOMETRY; FLU LIKE SYNDROME; HUMAN; HYPOTENSION; IMMUNOHISTOCHEMISTRY; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NATURAL KILLER T CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULAR ADNEXAL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION DOSE; REVIEW;

HUMANS; LYMPHOMA; ORBITAL NEOPLASMS;

EID: 34547920679     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3282be8fbb     Document Type: Review

References (21)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumors of haematopoeitic and lymphoid tissues: pathology and genetics. Lyon: IARC Press; 2001.
2. Coupland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases. Ophthalmology 1998; 105:1430-1441.
3. Farmer JP, Lamba M, McDonald H, Commons AS. Lymphoproliferative lesions of the lacrimal gland: clinicopathological, immunohistochemical and molecular genetic analysis. Can J Ophthalmol 2005; 40:151-160.
4. Esmaeli B, Ahmadi MA, Manning J, et al. Clinical presentation and treatment of secondary orbital lymphoma. Ophthal Plast Reconstr Surg 2002; 18:247-253.
5. Demirci H, Shields C, Shields J, et al. Orbital tumors in the older adult population. Ophthalmology 2002; 109:243-248.
6. Margo CE, Mulla ZD. Malignant tumors of the orbit: analysis of the Florida Cancer Registry. Ophthalmology 1998; 105:185-190.
7. Sullivan TJ, Whitehead K, Williamson R, et al. Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients. Ophthal Plast Reconstr Surg 2005; 21:177-188.
8. Sjo LD, Ralfkiaer E, Juhl BR, et al. Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study. Br J Ophthalmol 2006; 90:1004-1009.
9. Sullivan TJ, Valenzuela AA. Imaging features of ocular adnexal lymphoproliferative disease. Eye 2006; 20:1189-1195.
10. Valenzuela AA, Allen C, Grimes D, et al. Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology 2006; 113:2331-2337. The clinical impact of this paper is very relevant and every ophthalmologist should included PET in the staging process of any orbital lymphoma.
11. Roe RH, Finger PT, Kurli M, et al. Whole-body positron emission tomography/computed tomography imaging and staging of orbital lymphoma. Ophthalmology 2006; 113:1854-1858. The impact of PET/CT may be clinically relevant despite the study limits consisting especially of the small number of patients.
12. Suh CO, Shim SJ, Lee SW, et al. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior. Int J Radiat Oncol Biol Phys 2006; 65:228-233. This paper highlights the efficacy of radiotherapy on a large cohort of patients.
13. Ejima Y, Sasaki R, Okamoto Y. Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol 2006; 78:6-9. This paper highlights the efficacy of radiotherapy on a large cohort of patients and with a long follow-up.
14. Aviles A, Neri N, Calva A, et al. Addition of a short course of chemotherapy did not improve outcome in patients with localized marginal B-cell lymphoma of the orbit. Oncology 2006; 7:173-176. This is a prospective randomized study on the definitive treatment of this tumor, clearly eliminating the necessity of combining radiotherapy with chemotherapy.
15. Ben Simon G, Cheung N, McKelvie P, et al. Oral chlorambucile for extra-nodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit. Ophthalmology 2006; 113:1209-1213. This study offers a good alternative treatment, but it has a relatively short follow-up to draw definitive conclusions.
16. Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence of an association between Clamydia psittaci and ocular adnexal lymphoma. J Natl Cancer Inst 2004; 96:586-594.
17. Ferreri AJ, Ponzoni M, Guidoboni M, et al. Bacteria-eradicating therapy with doxycycline in ocular adnexal lymphoma: a multicentric prospective trial. J Natl Cancer Inst 2006; 98:1375-1382. The study was extremely well conducted and offers a revolutionary alternative for the treatment of lymphoma; it needs to stand the test of time and of further studies.
18. Rosado MF, Byrne GE Jr, Ding F, et al. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Clamydia psittaci. Blood 2006; 107:467-472. The authors describe a large series of patients affected by lymphoma without evidence of Clamydia psittaci infection.
19. Ferreri AJ, Viale E, Guidoboni M, et al. Clinical implications of hepatitis C infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol 2006; 17:769-772.
20. Sullivan TJ, Grimes D, Bunce I. Monoclonal antibody treatment of orbital lymphoma. Ophthal Plast Reconstr Surg 2004; 20:103-106.
21. Woog JJ, Kim YK, Yeatts RP, et al. Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology 2006; 113:140-145. This paper is the largest in a series of patients affected by this rare condition.